Women Infertility – Pipeline by Competitor Information, Analysis, and Insights to Formulate Effective R&D Strategies 2017

WiseGuyReports.com adds Exclusive Research on “Women Infertility” reports to its database.

PUNE, INDIA - October 13, 2017 /MarketersMedia/ —

SUMMARY

WiseGuyReports published new report, titled “Women Infertility - Pipeline Review, H2”

Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.
Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385306-women-infertility-pipeline-review-h2-2017

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 7, 16, 14, 1, 22, 9 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 2, 5 and 3 molecules, respectively.
Women Infertility (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Women Infertility (Women's Health).
- The pipeline guide reviews pipeline therapeutics for Women Infertility (Women's Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Women Infertility (Women's Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Women Infertility (Women's Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Women Infertility (Women's Health)

Key points to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Women Infertility (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Women Infertility (Women's Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents
Introduction
Women Infertility - Overview
Women Infertility - Therapeutics Development
Women Infertility - Therapeutics Assessment
Women Infertility - Companies Involved in Therapeutics Development
Women Infertility - Drug Profiles
Women Infertility - Dormant Projects
Women Infertility - Discontinued Products

..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: wiseguyreports
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349

Source URL: https://marketersmedia.com/women-infertility-pipeline-by-competitor-information-analysis-and-insights-to-formulate-effective-rd-strategies-2017/249960

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 249960

Latest News

Lawyers clash over impact of Trump's rules on birth control

Dec 13, 2017

OAKLAND, Calif. — Lawyers for California and the U.S. Department of Justice clashed in court Tuesday over whether new rules from President Donald Trump's administration would dramatically reduce women's access to free birth control. Deputy Assistant Attorney General Ethan Davis urged a federal judge not to grant the state's request to block the policy change to President Barack Obama's health care law, saying it was not clear any women would lose no-cost contraception coverage. The law required most companies to cover birth control at no additional cost, though it included exemptions for religious organizations. The new policy allows more categories...

San Francisco Mayor Edwin Lee leaves behind city in turmoil

Dec 13, 2017

SAN FRANCISCO — Under Mayor Ed Lee's seven-year watch, San Francisco went from a city mired in recession to a technology-fueled economic powerhouse where housing costs skyrocketed and the chasm between the wealthy and everyone else grew. Lee died Tuesday at 65 after collapsing while grocery shopping. He leaves behind a rapidly transforming city where the median home value is more than $1.2 million and grumpy residents are unhappy with homelessness, clogged traffic and frequent auto break-ins. Supporters touted his dedication to building new housing and sending out workers to clean up dirty streets in a city known for its...

Court keeps ban on new mining claims around Grand Canyon

Dec 13, 2017

FLAGSTAFF, Ariz. — A U.S. appeals court has kept in place an Obama-era ban on new mining claims around the Grand Canyon, but a review under the Trump administration is putting it in jeopardy. The decision Tuesday by the 9th U.S. Circuit Court of Appeals comes as a U.S. House committee heard testimony on access to minerals on public lands and dependence on foreign imports. The U.S. Forest Service under President Donald Trump has proposed reviewing the 20-year ban on new mining north and south of the Grand Canyon. Former President Barack Obama's Interior secretary made more than 1 million...

Tax package would lower top tax rate for wealthy Americans

Dec 13, 2017

WASHINGTON — Congressional Republicans on Tuesday rushed toward a deal on a massive tax package that would reduce the top tax rate for wealthy Americans to 37 percent and slash the corporate rate to a level slightly higher than what businesses and conservatives wanted. In a flurry of last-minute changes that could profoundly affect the pocketbooks of millions of Americans, House and Senate negotiators agreed to expand a deduction for state and local taxes to allow individuals to deduct income taxes as well as property taxes. The deduction is valuable to residents in high-tax states like New York, New Jersey...

NTSB blames captain, bad safety culture for loss of El Faro

Dec 13, 2017

A ship captain's unwillingness to listen to his crew's suggestions to change course from the path of a raging hurricane. A weak corporate safety culture that left crewmembers ill-prepared to deal with heavy weather. An old ship with outdated lifeboats, open to the elements. All these factors contributed to the sinking of the El Faro in the fury of Hurricane Joaquin on Oct. 1, 2015, which killed all 33 people on board, the National Transportation Safety Board announced on Tuesday. The report concludes a 2-year investigation into the worst U.S. maritime disaster in modern history. The NTSB issued 53 safety...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH